من المتوقع أن تصل قيمة تكنولوجيا الإنزيمات الطبية إلى 6,700.00 مليون دولار أمريكي بحلول عام 2028 مقارنة بـ 4,012.57 مليون دولار أمريكي في عام 2020؛ من المقدر أن تنمو بمعدل نمو سنوي مركب قدره 6.7٪ من عام 2021 إلى عام 2028.
تم تحليل سوق تكنولوجيا الإنزيمات الطبية على أساس نوع الإنزيم وتطبيقه وخصائصه. منطقة. يتم تقسيم السوق بناءً على المنطقة إلى أمريكا الشمالية وأوروبا وآسيا والمحيط الهادئ والشرق الأوسط وأفريقيا وأمريكا الجنوبية والوسطى. يركز التقرير على معايير مثل اتجاهات السوق، والتقدم التكنولوجي، وديناميكيات السوق، وتحليل المناظر الطبيعية التنافسية للشركة الرائدة لتقديم رؤى وتحليل متعمق لسوق تكنولوجيا الإنزيمات الطبية. ويتضمن أيضًا تحليل جائحة فيروس كورونا (COVID-19) عبر السوق في جميع المناطق الرئيسية.
المناطق المربحة لسوق تكنولوجيا الإنزيمات الطبيةرؤى السوق< /p>
التطورات في هندسة الإنزيمات ستظهر كاتجاه رئيسي في سوق تكنولوجيا الإنزيمات الطبية
تلعب هندسة الإنزيمات دورًا أساسيًا في تطوير المحفزات الحيوية الفعالة للتكنولوجيا الحيوية وعلوم الحياة والطب الحيوي. هندسة الإنزيمات هي عملية تصميم محفزات حيوية جديدة ذات خصائص محسنة عن طريق تغيير تسلسل الأحماض الأمينية الخاصة بها. على الرغم من ضخامة التعديلات المحتملة، فقد حقق هذا الإجراء بالفعل نتائج ملحوظة في شكل تصميمات فريدة وتحسين الإنزيمات للتخليق الحيوي الكيميائي والصيدلاني، والطب التجديدي، وإنتاج الغذاء، والتحلل الحيوي للنفايات، والاستشعار الحيوي.
وبصرف النظر عن ذلك، من التصميم العقلاني الكلاسيكي وأساليب التطور الموجه، يتم تطبيق أساليب التعلم الآلي (ML) بشكل متزايد للعثور على أنماط في البيانات التي تساعد على التنبؤ بهياكل البروتين؛ تحسين استقرار الإنزيم، والذوبان، والوظيفة؛ التنبؤ بخصوصية الركيزة. وتوجيه تصميم البروتين العقلاني. يعد التعلم الآلي هو النهج الثالث لتصميم المحفزات الحيوية الجديدة، والذي حظي بالاهتمام منذ العقود القليلة الماضية. على عكس أساليب التصميم العقلاني المبني على النماذج، تعتمد هذه الإستراتيجية على البيانات لأنها تحدد الأنماط في البيانات الموجودة للتنبؤ بخصائص مدخلات غير معروفة ولكنها مماثلة. في يناير 2020، أطلقت شركة Curative Enzymes، وهي شركة تقدم المنتجات والخدمات، خدمة هندسة وتعديل الإنزيمات لمساعدة العملاء الرئيسيين.
مع ظهور تقنيات وأساليب جديدة لإعادة بناء وهندسة الإنزيمات، يعمل العمل في هندسة البروتين. أصبح الأمر أكثر ملاءمة، حيث سلط الضوء على المحفزات الحيوية والجزيئات شبه الاصطناعية أو الاصطناعية الجديدة للتطبيقات الصناعية. وبالتالي، من المرجح أن تكون التطورات في هندسة الإنزيمات اتجاهًا سائدًا في السوق خلال الفترة المتوقعة.
رؤى قائمة على نوع الإنزيم
سوق تكنولوجيا الإنزيمات الطبية، حسب نوع الإنزيم، يتم تقسيمها إلى إنزيمات هضمية، وإنزيمات محللة للتخثر، وهيدرولاز، وإنزيمات نووية داخلية. استحوذ قطاع الهيدروليز على الحصة الأكبر من السوق في عام 2020؛ علاوة على ذلك، من المتوقع أن يسجل قطاع الإنزيمات الحالة للتخثر أعلى معدل نمو سنوي مركب بنسبة 7.2٪ في السوق خلال الفترة المتوقعة.
سوق تكنولوجيا الإنزيمات الطبية، حسب نوع الإنزيم - ndash; 2020 و2028
رؤى قائمة على التطبيقات
ينقسم سوق تكنولوجيا الإنزيمات الطبية، حسب التطبيق، إلى علاج الأمراض وأدوات التشخيص والأبحاث الطبية الحيوية وغيرها. استحوذ قطاع علاج الأمراض على الحصة الأكبر من السوق في عام 2020، ومن المتوقع أن يسجل نفس القطاع أعلى معدل نمو سنوي مركب بنسبة 7.1٪ في السوق خلال الفترة المتوقعة.
الرؤى الإستراتيجية
< p>تتبنى الشركات العاملة في سوق تكنولوجيا الإنزيمات الطبية استراتيجيات عضوية مثل إطلاق المنتجات والتوسعات لتوسيع نطاق تواجدها ومحفظة منتجاتها في جميع أنحاء العالم بالإضافة إلى تلبية الطلبات المتزايدة.حسب نوع الإنزيم
- الإنزيم الهضمي
- L-asparaginase
- اللاكتاز
- أخرى
- الإنزيم الحال للتخثر
- الستربتوكيناز
- اليوروكيناز
- أخرى
- إنزيم الهيدروليزات
- الهيالورونيداز
- الليزوزيز
- أخرى
- إنزيم نوكلياز داخلي
- بنزوناز
- أخرى
حسب التطبيق
- علاجات الأمراض
- أدوات التشخيص
- الأبحاث الطبية الحيوية
- أخرى
حسب الجغرافيا
- الشمال أمريكا
- الولايات المتحدة
- كندا
- المكسيك
- أوروبا
- فرنسا
- ألمانيا
- إيطاليا
- المملكة المتحدة
- إسبانيا
- بقية أوروبا
- آسيا والمحيط الهادئ (APAC)
- الصين
- الهند
- كوريا الجنوبية
- اليابان
- أستراليا< /li>
- بقية منطقة آسيا والمحيط الهادئ
- الشرق الأوسط وأفريقيا (MEA)
- جنوب أفريقيا
- المملكة العربية السعودية
- li>
- الإمارات العربية المتحدة
- باقي دول الشرق الأوسط وأفريقيا
- أمريكا الجنوبية والوسطى (SCAM)
- البرازيل < li>الأرجنتين
- باقي عمليات الاحتيال
الملفات التعريفية للشركة
- Merck
- Thermo Fisher Scientific Inc.
- Novozymes
- شركة TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Agilent Technologies, Inc.
- Danaher (Cytiva)
- Sanofi
- Asahi Kasei Corporation
- Promega Corporation
- Amano Enzyme Inc < لى>شركة جينزايم
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Enzymes are proteins produced in living cells of plants, animals, and microorganisms. All living organisms require enzymes for growth and for the production and utilization of energy which is essential for life. In the living cell, enzymes act as catalysts to speed up the chemical reactions which control life processes. Enzymes have been significant industrial products for more than a hundred years. However, the range of potential applications is increasing rapidly.
Key factors that are driving the market are advent of recombinant DNA technology, it has become possible to make formerly rare enzymes in large quantities and hence to reduce cost. Also, in pharmaceutical manufacturing, the desire to make chirally pure compounds is leading to new opportunities. Technological advances have facilitated the use of enzymes over an increasingly broad range of process conditions.
The costs of the Medical Enzyme Technology are much higher, and they may cost US$ 5–50, or more, per enzyme type. The cost may also differ from product to product types.
The List of Companies - Medical Enzyme Technology Market
- Merck
- Thermo Fisher Scientific Inc.
- Novozymes
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Agilent Technologies, Inc.
- Danaher (Cytiva)
- Sanofi
- Asahi Kasei Corporation
- Promega Corporation
- Amano Enzyme Inc
- Genzyme Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)